BioCryst Pharmaceuticals BCRX Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $173.38M+89.8% | $91.34M+8.6% | $84.08M-4.5% | $88.03M-17.6% | $106.88M+0.5% | ||
| $66.81M-63.9% | $185.01M+43.6% | $128.8M-25.1% | $172.01M-9.4% | $189.9M-12.1% | ||
| $109.27M+2.3% | $106.82M+17.0% | $91.33M+0.2% | $91.18M-2.4% | $93.39M+18.1% | ||
| $28.18M+17.4% | $23.99M+2.6% | $23.39M+5.3% | $22.21M-11.5% | $25.1M+8.2% | ||
| $373.63M-7.6% | $404.35M+13.7% | $355.68M-10.7% | $398.46M-2.8% | $409.98M-2.8% | ||
| $9.37M+6.7% | $8.78M+4.6% | $8.4M-0.7% | $8.46M+11.4% | $7.59M-2.4% | ||
| $465.05M-9.6% | $514.16M+15.2% | $446.42M-2.4% | $457.19M-4.8% | $480.05M-2.1% | ||
| $10.96M-30.8% | $15.83M+184% | $5.57M-35.2% | $8.59M-14.5% | $10.05M-13.7% | ||
| $5.41M— | $0— | —— | —— | —— | ||
| $1.24M-5.9% | $1.31M-8.6% | $1.44M-11.2% | $1.62M-10.0% | $1.8M-2.2% | ||
| $195.39M-0.3% | $196.07M+3.1% | $190.24M+7.4% | $177.16M+26.7% | $139.86M-12.8% | ||
| $395.2M— | $0-100% | $194.37M-19.9% | $242.79M-23.0% | $315.41M+0.2% | ||
| $1.02B+60.9% | $633.31M-24.1% | $834.31M-5.1% | $878.78M-5.7% | $931.97M-3.6% | ||
| 450M0.0% | 450M0.0% | 450M0.0% | 450M0.0% | 450M+21,483% | ||
| -$2.23B-47.9% | -$1.51B+14.0% | -$1.75B+0.7% | -$1.76B+0.3% | -$1.77B0.0% | ||
| -$553.84M-365% | -$119.15M+69.3% | -$387.89M+8.0% | -$421.59M+6.7% | -$451.93M+5.0% | ||
| $465.05M-9.6% | $514.16M+15.2% | $446.42M-2.4% | $457.19M-4.8% | $480.05M-2.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are BioCryst Pharmaceuticals's total assets?
- BioCryst Pharmaceuticals (BCRX) holds $465.1M in total assets, down 3.1% year over year.
- How much debt does BioCryst Pharmaceuticals have?
- BioCryst Pharmaceuticals carries $411.8M in total debt against -$553.8M of shareholders' equity, a debt-to-equity ratio of 0.14.
- How much cash does BioCryst Pharmaceuticals have?
- BioCryst Pharmaceuticals holds $173.4M in cash and equivalents.
- Can BioCryst Pharmaceuticals cover its short-term obligations?
- Its current ratio is 1.91 — current assets exceed current liabilities.
- Where does BioCryst Pharmaceuticals's balance sheet data come from?
- Every line is extracted from BioCryst Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
